{
    "nctId": "NCT04087057",
    "briefTitle": "Barriers Associated With Timely Adjuvant Chemotherapy Administration in Patients With Invasive Breast Cancer",
    "officialTitle": "Understanding Barriers Associated With Timely Chemotherapy Administration Among Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Invasive Breast Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 24,
    "primaryOutcomeMeasure": "Assessment of data collected from individual semi-structured interviews",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Diagnosed with primary invasive breast cancer\n* For patients receiving adjuvant chemotherapy: First dose of chemotherapy administered \\>= 60 days after definitive breast cancer surgery. For patient treated with neoadjuvant chemotherapy: First dose of chemotherapy administered \\>= 60 days after pathological diagnosis\n* Diagnosis of breast cancer within three years of study enrollment\n* Can speak, read, and understand English and/or Spanish\n* Patient of Lyndon B. Johnson General Hospital-Harris Health System (LBJ-HHS) or MD Anderson Cancer Center\n\nExclusion Criteria:\n\n* Women hospitalized for a critical condition or who are considered medically unstable by their medical team\n* Patients that started chemotherapy \\>= 3 years after definitive breast cancer surgery",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}